Kern Medical Chooses PrecisePK to Provide Bayesian Precision Dosing Solutions
SAN DIEGO, May 25, 2023-- Today, PrecisePK welcomes Kern Medical as its latest institution to implement innovations in precision dosing for vancomycin and other antibiotics using the Bayesian AUC-based method. "PrecisePK has helped to standardize and improve our vancomycin dosing workflow, and is especially suited to our diverse patient population since special patient factors, renal function calculations, and other components can be customized or factored into Bayesian prior selection," says Dr. Fang.
PrecisePk Pharm. D. Team
May 25, 2023
.png)
